When I recently heard about the joint venture between Avant Technologies and Ainnova Tech to develop VisionAI, it struck me as an example of a trend of AI in eye care: collaboration. This particular partnership pairs retinal cameras with artificial intelligence to detect diseases early, relying on the integration of clinical expertise, imaging devices, and AI analysis. It’s a great reminder that the best advancements in patient care happen when different players work together — collaboration as a catalyst for innovation.
This isn’t an isolated example. Partnerships like this are becoming more common as clinicians, device manufacturers, and AI developers work together. These collaborations streamline the entire process — from deciding to collect patient data to capturing it with the right devices and finally using AI to analyze it. It’s a holistic approach that’s reshaping how we diagnose and treat eye disease.
Real-World Examples of Collaboration
Collaboration is driving innovation in eye care, with partnerships across AI companies, device manufacturers, and pharmaceutical firms reshaping the way we diagnose and treat disease.
Take autonomous diabetic retinopathy solutions, for example. Companies such as AEYE, Eyenuk, and Digital Diagnostics are FDA cleared to work with specific devices from manufacturers such as Optomed, Canon, and Topcon. These collaborations benefit both sides: the device manufacturers see increased value and demand for their products when paired with FDA-cleared — and reimbursable — AI solutions.
RetinAI offers another example. Their work with Retina Consultants of America (RCA) focuses on analyzing real-world clinical and imaging data. By combining RCA’s datasets with RetinAI’s AI models, they’re building a resource to better understand treatment outcomes, medication adherence, and care effectiveness.
Device manufacturers are also advancing through platforms that integrate AI tools. Topcon’s Harmony platform hosts a variety of AI applications, while Heidelberg’s AppWay acts like an “app store” for solutions such as Altris, which assists with OCT interpretation. Even companies without devices, such as Unified Imaging, are entering the space with software that could integrate with AI solutions.
Pharmaceutical companies are making moves too. Boehringer Ingelheim, one of the largest pharmaceutical companies in the world, and Zeiss are collaborating to develop AI tools for earlier detection and treatment of retinal diseases, combining imaging and therapeutic expertise to prevent vision loss.
These partnerships show how collaboration is shaping the future of eye care by bringing together expertise from different sectors to improve outcomes and streamline care.
The Necessity of Partnerships
These collaborations aren’t just nice to have — they’re critical. It’s probably unrealistic to expect each device company to develop its own AI software when partnerships offer faster and more effective solutions. Just as the Apple iPhone and Google Android invite developers to build on their platforms, device manufacturers are wise to adopt a similar strategy, allowing them to concentrate on their core strengths.
For medical practices, especially larger ones with significant data repositories, leveraging that data to enhance patient care is a natural progression. They could develop proprietary algorithms tailored to their needs or use their data as a foundation to support broader AI models, driving innovation and better outcomes across the board.
The Challenge of Data Ownership
As we embrace these advancements, we have to address a critical issue: data ownership. AI relies heavily on patient data, and this raises questions about who owns that data, how it’s used, and who benefits from it. In the coming months in AI in Eye Care, we’ll dig deeper into this issue of data ownership and privacy in AI-powered eye care.
The future of eye care is all about collaboration. Doctors, devices, and AI need to work together to create systems that are efficient, ethical, and focused on delivering the best outcomes for patients.
Let’s keep pushing forward, together.
Author
